Difference between revisions of "Template:Drugs for functional gastrointestinal disorders"
Jump to navigation
Jump to search
imported>Anypodetos m (Simplify markup, replaced: • → • (48) using AWB) |
imported>Anypodetos |
||
(20 intermediate revisions by 14 users not shown) | |||
Line 2: | Line 2: | ||
| name = Drugs for functional gastrointestinal disorders | | name = Drugs for functional gastrointestinal disorders | ||
| title = Drugs for [[functional gastrointestinal disorder]]s ([[ATC code A03|A03]]) | | title = Drugs for [[functional gastrointestinal disorder]]s ([[ATC code A03|A03]]) | ||
− | | | + | | state = {{{state|autocollapse}}} |
+ | |listclass = hlist | ||
− | | group1 = Drugs for< | + | | group1 = Drugs for<br/> [[functional bowel disorder|functional<br/> bowel disorders]] |
− | | list1 = {{Navbox subgroup | + | | list1 = {{Navbox|subgroup |
− | |||
| group1 = [[Muscarinic antagonist|Antimuscarinic]]s | | group1 = [[Muscarinic antagonist|Antimuscarinic]]s | ||
− | | list1 = {{Navbox subgroup | + | | list1 = {{Navbox|subgroup |
− | |||
− | | group1 = Tertiary< | + | | group1 = Tertiary<br/> amino group |
− | | list1 = [[Oxyphencyclimine]] | + | | list1 = |
+ | * [[Oxyphencyclimine]] | ||
+ | * [[Camylofin]] | ||
+ | * [[Mebeverine]] | ||
+ | * [[Trimebutine]] | ||
+ | * [[Rociverine]] | ||
+ | * [[Dicycloverine]] | ||
+ | * [[Dihexyverine]] | ||
+ | * [[Difemerine]] | ||
+ | * [[Piperidolate]] | ||
− | | group2 = [[Quaternary ammonium]]< | + | | group2 = [[Quaternary ammonium|Quaternary<br/> ammonium]]<br/> compounds |
− | | list2 = [[Benzilone]] | + | | list2 = |
+ | * [[Benzilone]] | ||
+ | * [[Mepenzolate]] | ||
+ | * [[Pipenzolate]] | ||
+ | * [[Glycopyrronium bromide|Glycopyrronium]] | ||
+ | * [[Oxyphenonium bromide|Oxyphenonium]] | ||
+ | * [[Penthienate]] | ||
+ | * [[Methantheline]] | ||
+ | * [[Propantheline]] | ||
+ | * [[Otilonium bromide|Otilonium]] | ||
+ | * [[Tridihexethyl]] | ||
+ | * [[Isopropamide]] | ||
+ | * [[Hexocyclium]] | ||
+ | * [[Poldine]] | ||
+ | * [[Bevonium]] | ||
+ | * [[Diphemanil metilsulfate|Diphemanil]] | ||
+ | * [[Tiemonium iodide|Tiemonium]] | ||
+ | * [[Prifinium bromide|Prifinium]] | ||
+ | * [[Timepidium bromide|Timepidium]] | ||
+ | * [[Fenpiverinium]] | ||
}} | }} | ||
+ | | group2 = [[Phosphodiesterase inhibitor|Phosphodiesterase<br/> inhibitors]] | ||
+ | | list2 = | ||
+ | * [[Papaverine]] | ||
+ | * [[Drotaverine]] | ||
+ | * [[Moxaverine]] | ||
− | + | | group3 = Acting on<br/> [[5-HT receptor|serotonin receptors]] | |
− | + | | list3 = | |
− | + | * ''[[5-HT3 antagonist|5-HT<sub>3</sub> antagonists]]'' | |
− | | group3 = Acting on [[5-HT receptor|serotonin | + | **[[Alosetron]] |
− | | list3 = ''[[5-HT3 antagonist|5-HT<sub>3</sub> antagonists]]'' | + | ** [[Cilansetron]] |
+ | * ''[[Serotonin receptor agonist|5-HT<sub>4</sub> agonists]]'' | ||
+ | **[[Mosapride]] | ||
| group4 = Other | | group4 = Other | ||
− | | list4 = [[ | + | | list4 = |
+ | * [[Alverine]] | ||
+ | * [[Caroverine]] | ||
+ | * [[Chlorbenzoxamine]] | ||
+ | * [[Diisopromine]] | ||
+ | * [[Dimethylaminopropionylphenothiazine]] | ||
+ | * [[Fenpiprane]] | ||
+ | * [[Fenoverine]] | ||
+ | * [[Idanpramine]] | ||
+ | * [[Isometheptene]] | ||
+ | * [[Mentha piperita]] | ||
+ | * [[Phloroglucinol]] | ||
+ | * [[Pinaverium bromide]] | ||
+ | * [[Proxazole]] | ||
+ | * [[Silicones]] | ||
+ | * [[Tiropramide]] | ||
+ | * [[Trepibutone]] | ||
+ | * [[Trimethyldiphenylpropylamine]] | ||
}} | }} | ||
− | | group2 = [[ | + | | group2 = [[Atropa belladonna|Belladonna]]<br/> and derivatives<br/> ([[Muscarinic antagonist|antimuscarinic]]s) |
− | | list2 = '' | + | | list2 = |
+ | * ''Tertiary amines:'' [[Atropine]] | ||
+ | * [[Hyoscyamine]] | ||
− | '' | + | *''Quaternary ammonium compounds:'' |
+ | **[[Hyoscine hydrobromide|Scopolamine]] | ||
+ | ** [[Butylscopolamine]] | ||
+ | ** [[Methylscopolamine bromide|Methylscopolamine]] | ||
+ | * [[Methylatropine]] | ||
+ | * [[Fentonium bromide]] | ||
+ | * [[Cimetropium bromide]] | ||
| group3 = [[Prokinetic|Propulsive]]s | | group3 = [[Prokinetic|Propulsive]]s | ||
− | | list3 = ''[[dopamine antagonist| | + | | list3 = |
− | + | * ''[[dopamine antagonist|Primarily dopamine antagonists]]'' | |
− | + | ** [[Metoclopramide]]/[[Bromopride]] | |
− | + | ** [[Clebopride]] | |
− | + | ** [[Domperidone]] | |
− | + | ** [[Alizapride]] | |
− | + | * ''[[Serotonin receptor agonist|5-HT<sub>4</sub> agonist]]s'' | |
− | + | ** [[Cinitapride]] | |
− | + | ** [[Cisapride]] | |
}}<noinclude> | }}<noinclude> | ||
− | + | {{collapsible option}} | |
− | [[Category:Drug_templates by ATC | + | [[Category:Drugs acting on the gastrointestinal system and metabolism]] |
+ | [[Category:Drug_templates by ATC]] | ||
</noinclude> | </noinclude> |
Latest revision as of 14:08, 3 January 2021
Initial visibility: currently defaults to autocollapse
To set this template's initial visibility, the |state=
parameter may be used:
|state=collapsed
:{{Drugs for functional gastrointestinal disorders|state=collapsed}}
to show the template collapsed, i.e., hidden apart from its title bar|state=expanded
:{{Drugs for functional gastrointestinal disorders|state=expanded}}
to show the template expanded, i.e., fully visible|state=autocollapse
:{{Drugs for functional gastrointestinal disorders|state=autocollapse}}
If the |state=
parameter in the template on this page is not set, the template's initial visibility is taken from the |default=
parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse
.